{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:47:46Z","timestamp":1790200066747,"version":"4.1.0"},"reference-count":49,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11,15]]},"abstract":"<jats:p>This is the first report of molecular characterization of a novel cyclic nucleotide PDE (phosphodiesterase), isolated from the human malaria parasite Plasmodium falciparum and designated PfPDE1. PfPDE1 cDNA encodes an 884-amino-acid protein, including six putative transmembrane domains in the N-terminus followed by a catalytic domain. The PfPDE1 gene is a single-copy gene consisting of two exons and a 170\u00a0bp intron. PfPDE1 transcripts were abundant in the ring form of the asexual blood stages of the parasite. The C-terminal catalytic domain of PfPDE1, produced in Escherichia coli, specifically hydrolysed cGMP with a Km value of 0.65\u00a0\u03bcM. Among the PDE inhibitors tested, a PDE5 inhibitor, zaprinast, was the most effective, having an IC50 value of 3.8\u00a0\u03bcM. The non-specific PDE inhibitors IBMX (3-isobutyl-1-methylxanthine), theophylline and the antimalarial chloroquine had IC50 values of over 100\u00a0\u03bcM. Membrane fractions prepared from P. falciparum at mixed asexual blood stages showed potent cGMP hydrolytic activity compared with cytosolic fractions. This hydrolytic activity was sensitive to zaprinast with an IC50 value of 4.1\u00a0\u03bcM, but insensitive to IBMX and theophylline. Furthermore, an in vitro antimalarial activity assay demonstrated that zaprinast inhibited the growth of the asexual blood parasites, with an ED50 value of 35\u00a0\u03bcM. The impact of cyclic nucleotide signalling on the cellular development of this parasite has previously been discussed. Thus this enzyme is suggested to be a novel potential target for the treatment of the disease malaria.<\/jats:p>","DOI":"10.1042\/bj20050425","type":"journal-article","created":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T12:13:19Z","timestamp":1131451999000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite<i>Plasmodium falciparum<\/i>"],"prefix":"10.1042","volume":"392","author":[{"given":"Keizo","family":"Yuasa","sequence":"first","affiliation":[{"name":"Discovery Research Laboratories, Tanabe Seiyaku Co. Ltd., 2\u201350, Kawagishi 2-chome, Toda, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumika","family":"Mi-Ichi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, 3\u20131 Hongo-7-chome, Bunkyo-ku, Tokyo 113-0033, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, 3\u20131 Hongo-7-chome, Bunkyo-ku, Tokyo 113-0033, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratories, Tanabe Seiyaku Co. Ltd., 16\u201389, Kashima 3-chome, Yodogawa-ku, Osaka 532-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kotera","sequence":"additional","affiliation":[{"name":"Discovery Research Laboratories, Tanabe Seiyaku Co. Ltd., 2\u201350, Kawagishi 2-chome, Toda, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Kita","sequence":"additional","affiliation":[{"name":"Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, 3\u20131 Hongo-7-chome, Bunkyo-ku, Tokyo 113-0033, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Omori","sequence":"additional","affiliation":[{"name":"Discovery Research Laboratories, Tanabe Seiyaku Co. Ltd., 2\u201350, Kawagishi 2-chome, Toda, Saitama 335-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2005,11,8]]},"reference":[{"key":"2021112214100996700_B1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature (London)"},{"key":"2021112214100996700_B2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","article-title":"The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum","volume":"17","author":"Le\u00a0Bras","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"2021112214100996700_B3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/415673a","article-title":"The pathogenic basis of malaria","volume":"415","author":"Miller","year":"2002","journal-title":"Nature (London)"},{"key":"2021112214100996700_B4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0166-6851(90)90117-5","article-title":"Possible roles of Ca2+ and cGMP as mediators of the exflagellation of Plasmodium berghei and Plasmodium falciparum","volume":"42","author":"Kawamoto","year":"1990","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112214100996700_B5","first-page":"101","article-title":"The roles of Ca2+\/calmodulin- and cGMP-dependent pathways in gametogenesis of a rodent malaria parasite, Plasmodium berghei","volume":"60","author":"Kawamoto","year":"1993","journal-title":"Eur. J. Cell. Biol."},{"key":"2021112214100996700_B6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2958.2001.02665.x","article-title":"The gametocyte-activating factor xanthurenic acid stimulates an increase in membrane-associated guanylyl cyclase activity in the human malaria parasite Plasmodium falciparum","volume":"42","author":"Muhia","year":"2001","journal-title":"Mol. Microbiol."},{"key":"2021112214100996700_B7","doi-asserted-by":"crossref","first-page":"22147","DOI":"10.1074\/jbc.M001021200","article-title":"Guanylyl cyclase activity associated with putative bifunctional integral membrane proteins in Plasmodium falciparum","volume":"275","author":"Carucci","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1365-2958.2002.02948.x","article-title":"A novel cyclic GMP-dependent protein kinase is expressed in the ring stage of the Plasmodium falciparum life cycle","volume":"44","author":"Deng","year":"2002","journal-title":"Mol. Microbiol."},{"key":"2021112214100996700_B9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signalling: new phosphodiesterases and new functions","volume":"12","author":"Soderling","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"2021112214100996700_B10","first-page":"1","article-title":"Cyclic nucleotide phosphodiesterases: relating structure and function","volume":"65","author":"Francis","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"2021112214100996700_B11","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1073\/pnas.200355397","article-title":"Cloning and characterization of two splice variants of human phosphodiesterase 11A","volume":"97","author":"Hetman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214100996700_B12","doi-asserted-by":"crossref","first-page":"31469","DOI":"10.1074\/jbc.M003041200","article-title":"Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression","volume":"275","author":"Yuasa","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1385\/ENDO:23:2-3:135","article-title":"Therapy of ED: PDE-5 Inhibitors","volume":"23","author":"Shabsigh","year":"2004","journal-title":"Endocrine"},{"key":"2021112214100996700_B14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1527-3466.2001.tb00076.x","article-title":"Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake","volume":"9","author":"Liu","year":"2001","journal-title":"Cardiovasc. Drug Rev."},{"key":"2021112214100996700_B15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/1568010043343822","article-title":"The potential of PDE4 inhibitors in respiratory disease","volume":"3","author":"Spina","year":"2004","journal-title":"Curr. Drug Targets Inflamm. Allergy."},{"key":"2021112214100996700_B16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0020-7519(01)00164-3","article-title":"cAMP signalling in Trypanosoma brucei","volume":"31","author":"Seebeck","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"2021112214100996700_B17","doi-asserted-by":"crossref","first-page":"11559","DOI":"10.1074\/jbc.M005419200","article-title":"Characterization of TbPDE2A, a novel cyclic nucleotide-specific phosphodiesterase from the protozoan parasite Trypanosoma brucei","volume":"276","author":"Zoraghi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B18","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1073\/pnas.002031599","article-title":"Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei","volume":"99","author":"Rasc\u00f3n","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214100996700_B19","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1073\/pnas.062716599","article-title":"The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma brucei","volume":"99","author":"Zoraghi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214100996700_B20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science (Washington D.C.)"},{"key":"2021112214100996700_B21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"2021112214100996700_B22","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1073\/pnas.95.11.5857","article-title":"SMART, a simple modular architecture research tool: identification of signalling domains","volume":"95","author":"Schultz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214100996700_B23","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"2021112214100996700_B24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"2021112214100996700_B25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1550-7408.1983.tb02932.x","article-title":"Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients","volume":"30","author":"Rivadeneira","year":"1983","journal-title":"J. Protozool."},{"key":"2021112214100996700_B26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3600481","article-title":"Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3","volume":"360","author":"Sijwali","year":"2001","journal-title":"Biochem. J."},{"key":"2021112214100996700_B27","first-page":"69","article-title":"Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme","volume":"10","author":"Thompson","year":"1979","journal-title":"Adv. Cyclic Nucleotide Res."},{"key":"2021112214100996700_B28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"2021112214100996700_B29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1042\/bj3100965","article-title":"Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family","volume":"310","author":"McPhee","year":"1995","journal-title":"Biochem. J."},{"key":"2021112214100996700_B30","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/jm990014j","article-title":"Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes","volume":"42","author":"Kim","year":"1999","journal-title":"J. Med. Chem."},{"key":"2021112214100996700_B31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0165-6147(90)90066-H","article-title":"Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors","volume":"11","author":"Beavo","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"2021112214100996700_B32","doi-asserted-by":"crossref","first-page":"22477","DOI":"10.1016\/S0021-9258(17)31669-1","article-title":"Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase","volume":"269","author":"Francis","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0076-6879(90)83018-5","article-title":"Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project","volume":"183","author":"Senapathy","year":"1990","journal-title":"Methods Enzymol."},{"key":"2021112214100996700_B34","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","article-title":"Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2032,5\u2032-cyclic nucleotide phosphodiesterase","volume":"216","author":"Loughney","year":"1998","journal-title":"Gene"},{"key":"2021112214100996700_B36","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1074\/jbc.273.11.6460","article-title":"Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase","volume":"273","author":"Turko","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mol.56.1.124","article-title":"Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds","volume":"56","author":"Turko","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"2021112214100996700_B38","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1110\/ps.6601","article-title":"Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B","volume":"10","author":"Zhang","year":"2001","journal-title":"Protein Sci."},{"key":"2021112214100996700_B39","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"2021112214100996700_B40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/324364a0","article-title":"Control of malarial invasion by phosphorylation of the host cell membrane cytoskeleton","volume":"324","author":"Rangachari","year":"1986","journal-title":"Nature (London)"},{"key":"2021112214100996700_B41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0166-6851(80)90006-7","article-title":"Inhibition of malaria parasite invasion into erythrocytes pretreated with membrane-active drugs","volume":"1","author":"McColm","year":"1980","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112214100996700_B42","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00436-002-0690-8","article-title":"Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes","volume":"88","author":"Akaki","year":"2002","journal-title":"Parasitol. Res."},{"key":"2021112214100996700_B43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-6851(89)90023-6","article-title":"Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites","volume":"34","author":"Gero","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112214100996700_B44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0304-4165(68)90297-3","article-title":"Studies on the uptake of nucleic acid precursors into cells in tissue culture","volume":"158","author":"Scholtissek","year":"1968","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112214100996700_B45","first-page":"1974","article-title":"BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport","volume":"53","author":"Chen","year":"1993","journal-title":"Cancer Res."},{"key":"2021112214100996700_B46","doi-asserted-by":"crossref","first-page":"19607","DOI":"10.1016\/S0021-9258(19)47157-3","article-title":"Lysine 539 of human band 3 is not essential for ion transport or inhibition by stilbene disulfonates","volume":"264","author":"Garcia","year":"1989","journal-title":"J. Biol. Chem."},{"key":"2021112214100996700_B47","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1021\/bi00372a016","article-title":"Molecular mechanisms of band 3 inhibitors. 2. Channel blockers","volume":"25","author":"Falke","year":"1986","journal-title":"Biochemistry"},{"key":"2021112214100996700_B48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(81)90138-1","article-title":"Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader","volume":"46","author":"Pick","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"2021112214100996700_B49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0163-7258(91)90039-O","article-title":"Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function","volume":"51","author":"Thompson","year":"1991","journal-title":"Pharmacol. Ther."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/392\/1\/221\/639105\/bj3920221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/392\/1\/221\/639105\/bj3920221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T14:02:14Z","timestamp":1706709734000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/392\/1\/221\/44128\/PfPDE1-a-novel-cGMP-specific-phosphodiesterase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,8]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20050425","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,8]]}}}